This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.
Clinical trial NCT01250951 · COMPLETED
Trial details
- NCT number
- NCT01250951
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-07-01
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.